Happy Q4 Heart of Healthcare Listeners! We’re back with your monthly Digital Health Download, where we discuss the biggest industry headlines of the month. 

We cover: 

💊 Pharm tariffs, D2C drug ads, and TrumpRx? 

📉 The ACA tax credit standoff and how it could double premiums for millions 

🛒 UnitedHealthcare’s new storefront and what it signals about point solution fatigue

📈 The GLP-1 gold rush: Remedy’s $450M revenue, Virta’s $160M, and FDA’s warning shot 

⚖️ The Doximity vs. Open Evidence lawsuit that could define AI IP 

🤰 The acetaminophen-autism debate and why pregnant women deserve better data

—

Show notes:

• Virtual GLP-1 startups: Pill mills or the future of obesity care? (Halle Tecco)
• TrumpRx: A Prescription for Political Theater (Drugstore Cowboy)
• The future of metabolic health and weight loss drugs: Projecting mortality reductions in the US and UK populations (Swiss Re)
• The Latest in Maternal Health Fear Mongering? Tylenol (Vogue)

—

🙏 Thank you to our show sponsor, LookDeep. LookDeep pioneers AI that can see, hear, and respond with care to help hospitals be Ever Present for Every Patient. Learn more at lookdeep.ai/aimee. 

—

📍 Connect with us:

Heart of Healthcare website

TikTok (NEW!)

LinkedIn

Instagram

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Cancer drugs cost more than ever, yet survival benefits are often modest—and in some cases, patients can’t even access the care that already exists. 

After losing his father, Steve Jobs, to pancreatic cancer, Reed Jobs committed himself to making this the last generation that loses parents to the disease.

Reed now leads Yosemite, a venture fund spun out of Emerson Collective in 2023, alongside Investor Matt Bettonville. Yosemite pairs life sciences and digital health investments with a grantmaking model to accelerate cancer research and ensure breakthroughs actually reach patients.

We cover:

📉 The tension between drug pricing, patient access, and real-world value

🩺 Digital interventions that have outperformed cancer drugs in survival outcomes

🧪 Why phase 3 clinical trials are so costly, and how synthetic control arms could change that

🧬 The promise and limits of early detection—from liquid biopsies to at-home pap smears

🌍 The global race for healthcare innovation and why the U.S. can’t afford to fall behind

About our guests:

Reed Jobs is an Investor at Yosemite and manages Yosemite. Yosemite works exclusively in the oncology space, using flexible capital to advance science with the goal of making cancer non-lethal in our lifetime. Over the years, Reed has supported hundreds of researchers and invested in dozens of therapeutic, diagnostic and digital health companies across the U.S. and Europe. Before the launch of Yosemite, Reed served as the Managing Director of Health at Emerson Collective. He serves on the board of directors at Conservation International, Harvard Medical School, PICI, Stanford Medicine and Waverley Street Foundation. 

Matt Bettonville is an Investor at Yosemite where he leads the team’s investment efforts in digital health and healthcare delivery. He previously worked on Emerson Collective’s Count Me In non-profit partnership with the Broad Institute. Matt started his career working on user interface software engineering at Apple, where he was on the Mac team and a part of the AirPods product team. He holds a B.S. in Computer Science from Stanford University with a focus in Human-Computer Interaction. Matt serves on the board of directors at Atropos, Maia Oncology, Turquoise Health, Count Me In and Getlabs. He serves as a board observer at Proximie. 

—

🙏Thank you to our show sponsor, LookDeep. LookDeep pioneers AI that can see, hear, and respond with care to help hospitals be Ever Present for Every Patient. Learn more at lookdeep.ai/aimee.

—

📍 Connect with us:

Heart of Healthcare website

LinkedIn

Instagram

TikTok 

If you're enjoying the show, would you please leave us a review?

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Some founders win support because of their product, others because of their story. In healthcare, where trust is everything, the ability to tell a compelling and authentic narrative can make or break a company.

On this episode, Halle talks with longtime friend and colleague Christina Farr—reporter turned investor and now author of The Storyteller’s Advantage. Chrissy has spent thousands of hours hearing startup pitches, advising founders, and studying what makes certain stories resonate while others fall flat. She shares insights from her years as a journalist and investor, and lessons from her new book on how narrative power shapes companies and industries.

We cover:

📝 The three types of founder stories and why “personal experience” dominates in healthcare

📉 Why failure stories are scarce in healthcare—and how that holds founders back

🏆 The psychology of the underdog and how startups can use it to their advantage

📰 The double-edged sword of media attention, especially for women leaders

🎤 Why founder-led communications matter more than ever in an era of spammy PR pitches

About our guest:

Christina Farr is an editor-in-chief of the health-tech newsletter Second Opinion, which has 40,000 subscribers. She advises startups as a national advisor with Manatt, and she's a GP with the fund Scrub Capital. Prior to that, she worked as an investor at OMERS Ventures and a journalist with CNBC, Fast Company, and Reuters News. Her debut book "The Storyteller's Advantage" is now available. She was born and raised in London, U.K., and resides in New York with her husband and two children. 

—

If you're enjoying the show, we would so appreciate it if you left us a review!

—

📍 Connect with us:

Heart of Healthcare website

LinkedIn

Instagram

TikTok 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Thanks to improved accuracy and new form factors, wearables have evolved from novelty step counters to tools that can predict illness, nudge healthier behaviors, and even influence alcohol consumption. But can they really bridge the gap between consumer wellness and enterprise healthcare?

In this episode, ŌURA CEO Tom Hale discusses the lessons his team has learned from developing one of the most widely used health-tracking devices. We explore what draws people to wearables, what sustains their engagement, and how these tools may be shaping behavior and healthcare itself. 

We cover:

🕰️ The past, present, and future of wearables

🩺 What it takes to build trust with users, clinicians, and payers

🍷 The number one thing people do differently after wearing an Oura ring

🔑 Unlocking behavior change, and which habits are most malleable

🏥 Why payers and health systems are beginning to integrate wearables into care models

—

About our guest:

Tom Hale is the Chief Executive Officer at ŌURA and a member of its board. As the CEO he sets the company’s business strategy and vision to make health a daily practice for members all over the world. He has over 30 years of experience across the technology and consumer product industry.

Before joining ŌURA, Hale was president of Momentive where he drove B2B strategy and led product growth. During his time there he was instrumental in taking the company public in 2018, leading the team in key acquisitions, and driving the evolution and rebranding of the company into a multiple SAAS business. Previously, he held leadership roles at HomeAway and Linden Lab as the Chief Operating Officer and Chief Product Officer, respectively, and held executive roles at Macromedia and Adobe.

Hale has a Bachelor of Arts from Harvard University and sits on the boards of Cars.com, RocketReach, and NoiseAware.

—

If you're enjoying the show, we would so appreciate it if you left us a review!

—

📍 Connect with us:

Heart of Healthcare website

LinkedIn

Instagram

TikTok 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

AI companies are hitting growth milestones in record time—some reaching $100 million in revenue in just two years. But while this pace feels familiar in tech, healthcare has always been slower to adopt new tools. That may finally be changing.

Kent Bennett and Sofia Guerra of Bessemer Venture Partners join Steve Kraus to unpack findings from Bessemer’s State of AI 2025 report and what they mean for healthcare. From “supernovas” and “shooting stars” to the rise of systems of action, they explore how AI is reshaping not only software businesses but also the way doctors, health systems, and patients interact with technology.

We cover:

🚀 Why some AI companies are growing faster than the best SaaS businesses of the past decade

🏥 How healthcare AI adoption is starting to catch up with other industries

📊 The difference between systems of record and systems of action—and why it matters for doctors and patients

🔎 Whether general-purpose models like ChatGPT will dominate healthcare search, or if specialized tools will win out

⚖️ Why evals and data lineage may become make-or-break for safe AI deployment in healthcare

—

About our guests:

Sofia Guerra is a vice president at Bessemer Venture Partners, where she invests in seed to growth healthcare and life sciences companies. She is the co-author of State of Health Tech report, Benchmarks for Growing Health Tech Business, and how to scale health tech businesses to $100M and beyond, a study of 100+ best-in-class companies to understand key metrics relevant for scalability in healthcare software and tech-enabled services.

Sofia began her career as a consultant at Bain and Company, where she worked on strategy, operations, and due diligence projects across healthcare and technology.

Prior to joining Bessemer, she was an investor at BoxGroup Ventures and the co-founder and co-president of Nucleate, a national life sciences entrepreneurship program helping PhDs, Post-docs, and students commercialize scientific projects.

Sofia earned her MBA from Harvard Business School and her BA with high honors in Chemistry from Harvard University. While in school, she conducted research alongside Bob Langer, a serial entrepreneur and one of 12 Institute professors at MIT widely recognized for his contributions to drug delivery and tissue engineering fields.

She was born and raised in Guatemala, went to boarding school in Singapore for the last few years of high school, and has traveled to over 35 countries. In her free time, she enjoys listening and dancing to reguetón and traveling to new places with her fiancé Alex.

Kent Bennett is a partner in Bessemer’s Cambridge office focusing on B2B application software and consumer “earthquakes.”

Before his career in venture capital, Kent was a creative executive for an entertainment production company, where he developed and sold original material including a network television pilot and a feature film. He began his career with Bain & Co., where he worked on projects in industries spanning IT, retail, consumer products, healthcare, and biotech.

Kent earned an MBA from Harvard Business School, where he was a Baker Scholar, and graduated summa cum laude in systems engineering from the University of Virginia, where he was a Jefferson Scholar.

—

🙏Thank you to our show sponsor, LookDeep. LookDeep pioneers AI that can see, hear, and respond with care to help hospitals be Ever Present for Every Patient. Learn more at lookdeep.ai/aimee.

—

If you're enjoying the show, we would so appreciate it if you left us a review!

—

📍 Connect with us:

Heart of Healthcare website

LinkedIn

Instagram

TikTok 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Healthcare’s “back-to-school” season delivered no shortage of big headlines! From Epic’s big leap into AI to a looming insurance “blood bath,” Steve and Michael break down the stories that shaped digital health this month.

We cover:

🖥 Epic’s 200 new AI “colleagues” and what it means for the battle between systems of record vs. systems of action

💼 Why healthcare CEOs are cashing record paychecks despite shaky stock performance

📉 The warning signs of soaring insurance premiums and their political fallout heading into 2026

🤖 Hospitals turning to robots to fill critical workforce gaps

⚖ The wild policy divide on how AI should (or shouldn’t) be allowed to practice medicine

🎧 How an AI-powered stethoscope could change the way GPs catch heart disease

—

🙏Thank you to our show sponsor, LookDeep. LookDeep pioneers AI that can see, hear, and respond with care to help hospitals be Ever Present for Every Patient. Learn more at lookdeep.ai/aimee. 

—

📍 Connect with us:

Heart of Healthcare website

LinkedIn

Instagram

TikTok 

Substack

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Healthcare costs keep climbing, and yet patients and employers often feel powerless to change the system. What if outsiders—those not steeped in the traditions of healthcare—are actually the ones best positioned to fix it?

This special episode is a reshare from The Benefits Playbook podcast, where Halle joins Collective Health CEO Ali Diab. Together, they unpack what it takes to make health benefits simpler, more transparent, and more consumer-focused.

We cover:

🏥 The growing “consumer awakening” in healthcare and what it means for employers

🧾 How Ali’s personal fight with insurance denials led to building a new kind of health company

💡 Why outsiders can sometimes see solutions insiders overlook

🤖 Where AI can actually improve care—and where human advocates are still indispensable

💊 The GLP-1 dilemma for employers balancing access, equity, and cost

About our guest:

Ali Diab is the CEO and Co-Founder of Collective Health, the World’s leading independent third-party health benefit plan administrator (TPA), integrating AI-powered health plan administration, health benefit plan member navigation and advocacy, and digital benefits hub.

Ali has more than 25 years of experience leading high-growth technology organizations, and prior to co-founding Collective Health, was Vice President of Product Management and Business Operations at AdMob by Google. Previously, Ali held executive and management positions at Goldman Sachs, Microsoft, and Yahoo!. Ali is a graduate of Stanford and Oxford Universities and is a Member of the Board of Advisors of the Stanford Institute for Economic Policy Research (SIEPR).

—

🙏 If you're enjoying the show, we would so appreciate it if you left us a review!

—

📍 Connect with us:

Heart of Healthcare website

LinkedIn

Instagram

TikTok 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hospitals are under immense pressure: burned-out clinicians, outdated systems, and rising costs have made delivering care harder than ever. 

Tanay Tandon, founder and CEO of Commure, shares how his team is rethinking hospital infrastructure by combining AI, forward-deployed engineering, and a provider-first mindset. Backed by over $750M in funding, Commure is using strategic M&A and next-gen tools like ambient AI to reduce administrative burden, improve revenue cycle operations, and protect clinical staff.

We cover:

📉 How Commure grew claims volume 5x without hiring more staff

🧠 Why the “copilot” era of AI may give way to true automation in back-office tasks

🏥 Tanay’s prediction for a simpler, decentralized hospital system—powered by software

💰 What it means to take capital from General Catalyst’s Health Assurance Fund and build for its customer network

📰 How Commure navigated negative press around its business model and acquisitions

—

About our guest:

Tanay Tandon is CEO at Commure, a $6B healthcare software company. The business uses LLMs to help supercharge the productivity of clinicians, healthcare administrators, and finance teams. Commure has raised over $500 million, is backed by Sequoia Capital, General Catalyst, Initialized, YCombinator, and NVIDIA. The company’s technology powers daily workflows for 250,000 providers at over 100 major health systems.

—

🙏 If you're enjoying the show, we would so appreciate it if you left us a review!

—

📍 Connect with us:

Heart of Healthcare website

LinkedIn

Instagram

TikTok 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

One in four Americans is enrolled in Medicaid, yet the system designed to support them is constantly at risk—underfunded, politically vulnerable, and often overlooked.

Dr. Alastair Bell, President and CEO of Boston Medical Center Health System, shares how his organization is reimagining what it means to care for underserved populations, while managing nearly 40% of Massachusetts’ Medicaid enrollees. In this conversation, we explore the financial realities of running an “essential” hospital system, the opportunities and pitfalls of Medicaid ACOs, and why AI might deepen inequity if essential providers are left behind.

We cover:

 🏥 What makes an “essential” hospital system (and why the term matters)

 📊 How BMC manages risk across one of the largest Medicaid plans in New

 ⚖️ Why risk adjustment in Medicaid populations is still falling short

 💊 What the 340B drug pricing program really means for safety-net hospitals

 🧠 The promise (and peril) of AI in essential care settings

—

About our guest:

Dr. Alastair Bell oversees the comprehensive system strategy and operations of BMCHS' entities, including BMC, Boston Accountable Care Organization, Clearway Health, and the WellSense Health Plan.

Prior to joining in 2012, Dr. Bell was a leader in the North American payor and provider practice at McKinsey and Company, advising a range of national and international healthcare organizations and leading large-scale transformation programs. He received his Doctor of Medicine from the University of Oxford, his Master of Arts in physiology from the University of Cambridge, and his Master of Business Administration with distinction from Harvard Business School. Dr. Bell currently serves as co-chair of the board for the Boston Children’s Chorus.

—

🙏 If you're enjoying the show, we would so appreciate it if you left us a review!

—

📍 Connect with us:

Heart of Healthcare website

LinkedIn

Instagram

TikTok 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Three simple questions plague every American seeking healthcare: Where should I go? When can I be seen? And how much will it cost me? Despite seeming basic, these questions have remained largely unanswerable—until now.

In this episode, we explore how Heather Fernandez, co-founder and CEO of Solv, is building the infrastructure behind same-day care for 210 million Americans. We discuss how AI is finally cracking the code on price transparency and why workflow complexity can be a competitive moat in healthcare.

We cover: 

💰 Why price transparency has been so elusive and how AI tools are positioned to finally solve it 

🤖 How AI is eliminating "garbage work" and turning front desk staff into healthcare superheroes 

⚡ Why workflow expertise is a durable advantage for healthcare startups

🚀 How to build a culture of AI at your startup

💡 Why "intractable" problems may now be solvable

—

About our guest: 

Heather Fernandez is the CEO and co-founder of Solv Health, a leading platform redefining access to everyday healthcare. Solv connects consumers with a national network of providers, enabling same-day appointment availability and price transparency for patients across the country. For providers, the Solv platform acts as a growth copilot, leveraging AI to eliminate unnecessary administrative work, optimize existing capacity, and modernize the patient experience through our voice agent Maya and ClearPay price transparency. Solv integrates with EHR systems to streamline scheduling, intake, messaging, patient payments, and insights. To date, Solv has powered over 100 million visits nationwide with providers like Yale New Haven Health, GoHealth and ZoomCare.

Heather has built her career around intuitive, transparent consumer experiences, previously helping scale Trulia through its acquisition by Zillow. She serves on Atlassian’s Board of Directors and is a graduate of UC Berkeley and Stanford GSB.

—

🙏 If you're enjoying the show, we would so appreciate it if you left us a review!

—

📍 Connect with us:

Heart of Healthcare website

LinkedIn

Instagram

TikTok 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.